Hosted by the City of Gothenburg and Region Västra Götaland
PRELIMINARY PROGRAM
The program may be subject to change
Wednesday March 29, 9.00-12.00 - Pre-Course
Johan Zelano and Francesco Brigo
Conference room: Europa
09.00-09.15 Welcome
Francesco Brigo, Johan Zelano
09.15-10.00 Diagnosis of epilepsy in the context of other brain disease: application of the ILAE definition
Johan Zelano
10.00-10.30 Coffee break
10.30-11.15 Management of a seizures of different etiologies: stroke, TBI, CNS infections. What evidence is there?
Francesco Brigo
11.15-11.30 Drug resistant structural epilepsy
Francesco Brigo
11.30-12.00 Health impact of different acquired epilepsies – an introduction
Johan Zelano
12.00 Lunch
for delegates at the pre-course
Wednesday March 29, 13.00-17.00 - STESS conference
Conference room: Wallenbergsalen
Session 1: Preclinical / epileptogenesis / disease modification
13.00-13.10 Opening remarks
Francesco Brigo and Johan Zelano
13.10-13.50 The immune system in epileptogenesis
Alberto Vogrig, Italy
13.50-14.30 Mechanisms of epileptogenesis in preclinical studies
Emilio Russo, Italy
14.30-15.00 Coffee break
15.00-15.40 Modulating epileptogenesis: past and present human trials
Eugen Trinka, Austria
15.40-16.20 Is there familial vulnerability for symptomatic epilepsies?
Jakob Christensen, Denmark
16.20-17.15 Platform session
3x15 min presentations.
17.15-18.00 Sponsored symposium
TBA
18.00-19.30 Welcome reception
Hosted by the City of Gothenburg and Region Västra Götaland
Thursday March 30 - STESS Conference
Session 2: Risk factors and biomarkers
09.00-09.40 The value of EEG as biomarker of epileptogenesis and seizures recurrence in different acquired epilepsies
Carla Bentes, Portugal
09.40-10.20 Reperfusion therapies and the risk of poststroke epilepsy
Petra Redfors, Sweden
10.20-10.50 Coffee break
10.50-11.30 The immune reaction as a potential biomarker in epilepsy
Christine Ekdahl, Sweden
11.30-12.00 Platform session
2x15 min presentations
12.00-12.25 Lunch
12.25-13.25 Sponsored lunch symposium, Eisai
Session 3: Diagnosis, treatment and prognosis
13.25-14.05 Serum biomarkers for the diagnosis of structural acquired epilepsies
Laura Abraira, Spain
14.05-14.35 Tailored ASM selection in acquired epilepsy based on big data
Johan Zelano, Sweden
14.35-15.00 Coffee break
15.00-15.40 Predicting treatment resistance in acquired epilepsies
Simona Lattanzi, Italy
15.40-16.20 Prognosis of symptomatic epilepsies: the impact on survival
Rob Rouhl, The Netherlands
16.20-17.10 Platform session
3x15 min presentations
Friday March 31 - STESS Conference
Session 4: Prognosis continued, Hot topics
09.00-09.40 Drug withdrawal in structural epilepsies
Morten Lossius, Norway
09.40-10.20 Epilepsy surgery for symptomatic epilepsies
Reetta Kälviäinen, Finland
10.20-10.50 Coffee break
10.50-11.30 Seizures in and after brain infections
Ley Sander, UCL, UK.
11.30-12.00 NORSE and FIRES in adults and children - Do we need to think differently?
Ronny Wickström, Sweden
12.00-12.15 Closing remarks
Johan Zelano and Francesco Brigo
12.15 Lunch
Last update: 2023-01-31
